Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Boyd

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesR Karl Malcolm, Ronald S Veazey, Leslie Geer, et al.
Alzheimer'S Research & Therapy|April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairmentErica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
International Journal of Pharmaceutics|August 28, 2025
A prodrug strategy for sustained release of lactic acid from silicone elastomer vaginal ringsYahya H Dallal Bashi, Xinyu Zhao, Clare F McCoy, et al.
Rheumatology International|October 14, 2024
Correction to: Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studiesEsha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
Rheumatology International|April 12, 2024
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD StudiesEsha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
International Journal of Rheumatic Diseases|May 14, 2024
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD groupRusska Shumnalieva, Naveen Ravichandran, Jennifer Hannah, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesR Karl Malcolm, Ronald S Veazey, Leslie Geer, et al.
Alzheimer'S Research & Therapy|April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairmentErica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
International Journal of Pharmaceutics|August 28, 2025
A prodrug strategy for sustained release of lactic acid from silicone elastomer vaginal ringsYahya H Dallal Bashi, Xinyu Zhao, Clare F McCoy, et al.
Rheumatology International|October 14, 2024
Correction to: Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studiesEsha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
Rheumatology International|April 12, 2024
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD StudiesEsha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
International Journal of Rheumatic Diseases|May 14, 2024
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD groupRusska Shumnalieva, Naveen Ravichandran, Jennifer Hannah, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
Pageof 7